V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases

J Vaishnav, F Khan, M Yadav, N Parmar, H Buch… - Immunobiology, 2022 - Elsevier
Autoimmunity eventuates when the immune system attacks self-molecules as a result of the
breakdown in immune tolerance. Targeting autoimmune diseases via immunomodulation …

Elevated X-box binding protein1 splicing and interleukin-17A expression are associated with active generalized vitiligo in Gujarat population

SD Jadeja, J Vaishnav, AH Bharti… - Frontiers in immunology, 2022 - frontiersin.org
Vitiligo is an autoimmune skin disorder defined by the destruction of functional epidermal
melanocytes. It is a multifactorial and polygenic disorder caused due to oxidative stress …

Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an …

S Pehlivan, Y Oyaci, FC Tuncel, HM Aytac - Egyptian Journal of Medical …, 2022 - Springer
Background Pro-inflammatory/anti-inflammatory cytokine imbalance in cerebrospinal fluid or
plasma of schizophrenia (SCZ) and bipolar disorder (BD) patients has been documented …

Variations in TAP1 and PSMB9 Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community

AH Mufti, IA AlJahdali, NA Elhawary… - … Journal of General …, 2021 - Taylor & Francis
Background The antigen processing 1 (TAP1) and proteasome 20S subunit beta 9 (PSMB9)
genes are associated with strong susceptibility to many autoimmune diseases. Here, we …

Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma

S Cauci, C Buligan, F Rocchi, I Salvador… - Oncology …, 2019 - spandidos-publications.com
Immunity and cytokines serve crucial roles in cutaneous melanoma. The present study
investigated whether a variable number tandem repeat (VNTR) polymorphism of interleukin …

The immunogenetics of vitiligo: An approach toward revealing the secret of depigmentation

M Dwivedi, NC Laddha, R Begum - The Immunogenetics of Dermatologic …, 2022 - Springer
Vitiligo is a hypomelanotic skin disease and considered to be of autoimmune origin due to
breaching of immunological self-tolerance, resulting in inappropriate immune responses …

[HTML][HTML] Interleukin 1α and interleukin 18 in patients with vitiligo–Results of a case-control study

B Nieradko-Iwanicka, D Przybylska… - Biomedicine & …, 2023 - Elsevier
Introduction Vitiligo is a depigmenting disorder resulting from loss of functional melanocytes
in the skin. Variety of inflammatory mediators participate in the regulation of melanogenesis …

Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms

I Serin, Y Oyaci, M Pehlivan, S Pehlivan - Cytokine, 2022 - Elsevier
Introduction The IL-1 receptor antagonist (IL-1Ra or IL-1RN) is a member of the IL-1
superfamily that functions as a competitive antagonist of the cell surface IL-1 receptor …

Genetic polymorphism of interleukin-1 receptor antagonist in Type 1 diabetic children

NT Abed, IA Ramadan, SA Mohammed… - Pediatric …, 2022 - nature.com
Background Interleukin-1 receptor antagonist (IL1RN) variable number tandem repeats
(VNTRs) are not fully understood in Type 1 diabetes mellitus (T1DM). It may affect IL1RN …

Expression analysis of candidate genes in vitiligo patients & effect of oxidative stress on melanocytes

M Singh, J Vaishnav, A Shah, R Begum - Gene Reports, 2021 - Elsevier
Background Vitiligo is an acquired hypomelanotic autoimmune disorder characterized by
depigmented macules on the skin. Oxidative stress acts as an initial trigger and …